Should You Accumulate Novocure Ltd (NVCR) Stock Thursday Morning?

Novocure Ltd (NVCR) is lower by Thursday morning, with the stock falling -1.09% in pre-market trading to 14.48. NVCR's short-term technical score of 13 indicates that the stock has traded less bullishly over the last month than 87% of stocks on the market. In the Medical Devices industry, which ranks 118 out of 146 industries, Novocure Ltd ranks higher than 23% of stocks. Novocure Ltd has fallen 1.74% over the past month, closing at $15.31 on February 29. During this period of time, the stock fell as low as $13.07 and as high as $18.04. NVCR has an average analyst recommendation of Buy. The company has an average price target of $25.29.

NVCR has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on NVCR!

See Full NVCR Report

Novocure Ltd has a Long-Term Technical rank of 33. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 67% of the market scoring higher. In the Medical Devices industry which is number 115 by this metric, NVCR ranks better than 115% of stocks.

Important Dates for Investors in NVCR:

-Novocure Ltd is set to release earnings on 2024-05-02. Over the last 12 months, the company has reported EPS of $-1.86. -We do not have a set dividend date for Novocure Ltd at this time. Click Here To Get The Full Report on Novocure Ltd (NVCR)